UnitedHealth Group stock holds steady as earnings and guidance stay central

UnitedHealth Group (US91324P1021) remains a benchmark name in US managed care, and its latest reported numbers still set the tone for the stock. The company posted revenue of $371.6 billion for fiscal 2025, after $400.3 billion in revenue for full-year 2024, while adjusted diluted earnings per share reached $27.66 in 2025 versus $27.54 in 2024.

Revenue at $371.6 billion

The scale remains the main story. UnitedHealth reported $371.6 billion in revenue for fiscal 2025, and the figure followed $400.3 billion in 2024, giving investors a clear year-over-year reference point for the business after a strong prior year base.

Adjusted diluted EPS was $27.66 in 2025, edging above $27.54 in 2024. That 0.4% increase is modest, but it shows how closely earnings are tracking the company size rather than relying on a one-off jump.

EPS up 0.4%

The earnings comparison matters because it gives context to the revenue trajectory. UnitedHealth also reported operating cash flow of $32.8 billion in 2025, which followed $32.6 billion in 2024 and kept cash generation in a broad steady range.

That combination of $371.6 billion in revenue, $27.66 in adjusted EPS and $32.8 billion in operating cash flow gives the stock three dated anchors from the latest annual results. For readers tracking the shares, the more important question is not whether the company is big, but whether earnings can keep pace with that size.

Cash flow stays large

UnitedHealth Group has also continued to present itself as a diversified healthcare platform rather than a single-line insurer. The annual figures show why: the company has both scale and recurring cash generation, two qualities that often matter more than short-term noise in a large-cap healthcare name.

That matters in a stock that investors usually assess through fundamentals rather than story stock momentum. The annual report numbers provide a cleaner lens than market chatter: revenue, earnings and cash flow all remain at very large absolute levels.

Optum remains the scale driver

Optum is the most representative business line to watch because it combines services, care delivery and data-driven healthcare operations. The segment remains central to UnitedHealth's earnings mix and is the part of the company most closely watched for margin durability and growth consistency.

For a market-cap heavyweight like UnitedHealth, that segment matters because it links the insurance side with the healthcare services side. Investors typically look there first when they want to understand whether the group can keep generating cash at the current scale.

Annual numbers still matter

UnitedHealth Group stock is best read through the latest annual numbers rather than through a short-term trading lens. The company reported $371.6 billion in revenue for 2025, $27.66 in adjusted diluted EPS and $32.8 billion in operating cash flow, with each figure giving the stock a dated reference point.

The shares trade on the NYSE under UNH, and the latest annual results remain the most useful framework for assessing the company. In a large healthcare name, the mix of revenue scale, EPS and cash flow still defines the stock story more than any single session.